Biomarker Progressions Explain Higher Variability in Stage-Specific Cognitive Decline than Baseline Values in Alzheimer Disease

BACKGROUND: It is unknown which commonly employed Alzheimer disease biomarker values-baseline or progression-best predict longitudinal cognitive decline. METHODS: 526 subjects from the Alzheimer’s Disease Neuroimaging Initiative. ADNI composite memory (ADNI-Mem) and executive (ADNI-Exe) scores were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Dodge, Hiroko H., Zhu, Jian, Harvey, Danielle, Saito, Naomi, Silbert, Lisa C., Kaye, Jeffrey A., Koeppe, Robert A., Albin, Roger L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4253728/
https://ncbi.nlm.nih.gov/pubmed/25022534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.04.513
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados